Oxycodone/Aspirin/Dextromethorphan

羟考酮/阿司匹林/右美沙芬

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOxycodone/Aspirin/Dextromethorphan

Drug Alias NameOxycodone+Aspirin+Dextromethorphan羟考酮-阿司匹林-右美沙芬Oxycodone/acetylsalicylic acid/Dextromethorphan羟考酮+阿司匹林+右美沙芬Oxycodone-Aspirin-Dextromethorphan +[8]

ClassificationSmall molecules

Mechanisms of ActionCyclooxygenases inhibitorsOpioid receptors agonistsGlutamate [NMDA] receptor antagonists

TargetsOpioid receptorsGlutamate [NMDA] receptorCyclooxygenases

Therapy Area/IndicationsPain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Oxycodone Aspirin Dextromethorphan Hydrobromide

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEndo International Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEndo International Plc

Active IndicationsN/A

Inactive IndicationsPain

Other Information

ATC CodeN/A